Central Venous Catheter Occlusion
📧 Sign up to get email alerts when something new happens for Central Venous Catheter Occlusion.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-10-08FDA Approved: CATHFLO ACTIVASE — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Cathflo Activase (alteplase) submitted by Genentech. The approval covers a supplemental indicati…
-
FDA label_change · 2018-02-28FDA Approved: CATHFLO ACTIVASE — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Cathflo Activase (alteplase) from Genentech, resulting in labeling/indication changes for the pr…
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: Efficacy and Safety of Actilyse 2 mg/ 2 ml in Comparison to Saline Solution in Patients With Central Venous Access Device Occlusion [Phase 3]
Phase 3 trial evaluating Actilyse (alteplase) 2 mg/2 mL versus saline for treating central venous catheter occlusion, assessing efficacy and…